CAPR icon

Capricor Therapeutics
CAPR

Overview Fund Trends Analyst Outlook Journalist POV

30 hedge funds and large institutions have $10.1M invested in Capricor Therapeutics in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

3% less funds holding

Funds holding: 31 → 30 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$739K
Puts
$390K
Net Calls
Net Calls Change

Top Buyers

1
+$71K
2
+$56.9K
3
+$31.7K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$23.5K
5
TRCT
Tower Research Capital (TRC)
New York
+$21.5K

Top Sellers

1
-$399K
2
-$274K
3
-$204K
4
BlackRock
BlackRock
New York
-$190K
5
CSS
Cubist Systematic Strategies
Connecticut
-$113K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4.96K
27
$3K
28
$3K
29
$249
30
$126
31
–
32
–
33
–
34
–
35
–
36
–
37
–
1
2